Liu Jin, Pan Xiaohua, Sun Yan, Dong Tingting, Hu Xiao, Zhong Huijuan, Lu Jianwei
The Department of Oncology, The Affiliated Suqian First People's Hospital of Nanjing Medical University and Suqian First Hospital, Suqian 223800, China.
The Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing 210000, China.
J Oncol. 2022 Aug 17;2022:4440098. doi: 10.1155/2022/4440098. eCollection 2022.
This study aims at investigating the differences of clinicopathological features and postoperative prognosis in three different types of neuroendocrine differentiation-related gastric cancers.
From January 1, 2015 to September 30, 2016, 47 patients diagnosed with neuroendocrine differentiation-related gastric cancers were collected from 1095 patients with gastric cancer who underwent surgical treatment in the Department of Gastrointestinal Surgery, Jiangsu Cancer Hospital. Patients were followed up regularly, and the last follow-up time was October 25, 2021. A total of 38 cases met the inclusion criteria and completed follow-up. The clinicopathological characters and immunohistochemical results of these three special pathological types of gastric cancer (adenocarcinoma with neuroendocrine differentiation, mixed adenoneuroendocrine carcinoma, and neuroendocrine carcinoma of the stomach) patients were compared. Tissues from these patients were tested with immunohistochemical markers synaptophysin (Syn), chromogranin A (CgA), and Ki-67. The Kaplan-Meier method and log-rank test were used to analyze the effect of different histological types of gastric cancer on overall survival (OS). The differences in positive rates of chromogranin A (CgA) and Ki-67 were analyzed by univariate Cox regression analysis as independent risk factors that may affect the survival of gastric cancer patients.
Ki-67 and N staging were significantly correlated with OS in gastric cancer patients and were independent prognostic factors affecting the survival of gastric cancer patients. There was no statistical difference in OS between the two histopathological types (adenocarcinoma with neuroendocrine differentiation and mixed adenoneuroendocrine carcinoma) of gastric cancer patients. There were no significant differences in the positive rates of immunohistochemical markers Syn, CgA, and Ki-67 in gastric cancer patients with different histological types.
The combined detection of Syn and CgA is of great value for the diagnosis of neuroendocrine differentiation-related gastric cancers, Ki-67 is of significance for the prognosis prediction of neuroendocrine differentiation-related gastric cancers, regional lymph node metastasis has a great impact on tumor prognosis, and the N staging determines the necessity of postoperative adjuvant chemotherapy for patients with neuroendocrine differentiation-related gastric cancer.
本研究旨在探讨三种不同类型神经内分泌分化相关胃癌的临床病理特征及术后预后差异。
2015年1月1日至2016年9月30日,从江苏省肿瘤医院胃肠外科接受手术治疗的1095例胃癌患者中收集47例诊断为神经内分泌分化相关胃癌的患者。对患者进行定期随访,最后随访时间为2021年10月25日。共有38例符合纳入标准并完成随访。比较这三种特殊病理类型胃癌(神经内分泌分化腺癌、腺神经内分泌混合癌和胃神经内分泌癌)患者的临床病理特征及免疫组化结果。用免疫组化标志物突触素(Syn)、嗜铬粒蛋白A(CgA)和Ki-67检测这些患者的组织。采用Kaplan-Meier法和log-rank检验分析不同组织学类型胃癌对总生存期(OS)的影响。通过单因素Cox回归分析分析嗜铬粒蛋白A(CgA)和Ki-67阳性率的差异,作为可能影响胃癌患者生存的独立危险因素。
Ki-67和N分期与胃癌患者的OS显著相关,是影响胃癌患者生存的独立预后因素。胃癌患者的两种组织学类型(神经内分泌分化腺癌和腺神经内分泌混合癌)之间的OS无统计学差异。不同组织学类型胃癌患者免疫组化标志物Syn、CgA和Ki-67的阳性率无显著差异。
Syn和CgA联合检测对神经内分泌分化相关胃癌的诊断具有重要价值,Ki-67对神经内分泌分化相关胃癌的预后预测具有重要意义,区域淋巴结转移对肿瘤预后有很大影响,N分期决定神经内分泌分化相关胃癌患者术后辅助化疗的必要性。